Jonathan Brooks

Jonathan Brooks discloses dealings in 3 companies, chiefly Bowlin Travel Centers Inc, BioCardia, Inc. and Maguire Properties Inc. Over a trading history stretching from 17 March 2006 to 10 May 2016, the count stands at 16 filings.

Market trades split into 2 purchases (€5,247) and 13 sales (€3.2M). Taken together, the sales exceed the purchases by €3.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. Since January 2016: no purchases and 1 sale on the market.

On 11 May 2016 came the latest disclosure, an open-market sale for €2.8M in BioCardia, Inc. The last insider purchase was made public on 15 May 2014, 4,545 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.